Skip to content

Platelet-rich plasma injections and platelet-rich fibrin to enhance the wound healing in pressure injury

Platelet-rich plasma injections and platelet-rich fibrin to enhance the wound healing in pressure injury

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027248
Enrollment
Unknown
Registered
2019-11-06
Start date
2019-11-18
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pressure injury

Interventions

PRP alone group:PRP injections into the wound edge
PRP+PRF group:PRP injection into the wound edge and PRF covering the wound
normal wound care group:Normal wound care including cleaning and dressing changing

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. aged over 18 years; 2. pressure injury classification: stage III, IV and suspected deep tissue injury. Stage III: Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon or muscle are not exposed. Stage IV: Full thickness tissue loss with exposed bone, tendon or muscle. Slough or eschar may be present on some parts of the wound bed. Often include undermining and tunneling. Suspected deep tissue injury: Purple or maroon localized area of discolored intact skin or blood-filled blister due to damage of underlying soft tissue from pressure and/or shear. The area may be preceded by tissue that is painful, firm, mushy, boggy, warmer or cooler as compared to adjacent tissue.

Exclusion criteria

Exclusion criteria: 1. pressure injury with osteomyelitis; 2. acute infectious disease with premonitory symptoms; 3. hematological system diseases; 4. allergic constitution; 5. severe heart, liver, kidney or lung function failure; 6. immune disease; 7. pregnant or lactating women; 8. medication history on antiplatelet agents or anticoagulants within 1 week or long-term history; 9. poor compliance.

Design outcomes

Primary

MeasureTime frame
PressureUlcer Scale for Healing ,PUSH;wound area;

Secondary

MeasureTime frame
healing speed;

Countries

China

Contacts

Public ContactHe Hongchen

West China Hospital, Sichuan University

66362265@qq.com+86 18980602262

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026